IQVIA to Announce Second-Quarter 2021 Results on July 27, 2021
July 13 2021 - 4:15PM
Business Wire
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its
second-quarter 2021 financial results before the market opens on
Tuesday, July 27, 2021. The IQVIA management team will also host a
conference call and webcast at 9:00 a.m. Eastern Time on that date.
The earnings release and accompanying financial information will be
posted on the IQVIA Investor Relations website at
http://ir.iqvia.com.
To listen to the event and view the presentation slides via
webcast, join from the IQVIA Investor Relations website at
http://ir.iqvia.com. To participate in the conference call,
interested parties must register in advance by clicking on this
link. Following registration,
participants will receive a confirmation email containing details
on how to join the conference call, including the dial-in and a
unique passcode and registrant ID. At the time of the live event,
registered participants connect to the call using the information
provided in the confirmation email and will be placed directly into
the call.
A replay of the webcast will be available approximately two
hours after the conclusion of the live event. To access the webcast
recording, visit http://ir.iqvia.com.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced
analytics, technology solutions, and clinical research services to
the life sciences industry. IQVIA creates intelligent connections
across all aspects of healthcare through its analytics,
transformative technology, big data resources and extensive domain
expertise. IQVIA Connected Intelligence™ delivers powerful insights
with speed and agility — enabling customers to accelerate the
clinical development and commercialization of innovative medical
treatments that improve healthcare outcomes for patients. With
approximately 72,000 employees, IQVIA conducts operations in more
than 100 countries.
IQVIA is a global leader in protecting individual patient
privacy. The company uses a wide variety of privacy-enhancing
technologies and safeguards to protect individual privacy while
generating and analyzing information on a scale that helps
healthcare stakeholders identify disease patterns and correlate
with the precise treatment path and therapy needed for better
outcomes. IQVIA’s insights and execution capabilities help biotech,
medical device and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders tap
into a deeper understanding of diseases, human behaviors, and
scientific advances, to advance their path toward cures. To learn
more, visit www.iqvia.com.
IQVIAFIN
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210713006074/en/
Nick Childs, IQVIA Investor Relations
(nicholas.childs@iqvia.com) +1.973.316.3828
Tor Constantino, IQVIA Media Relations
(tor.constantino@iqvia.com) +1.484.567.6732
IQVIA (NYSE:IQV)
Historical Stock Chart
From Aug 2024 to Sep 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
From Sep 2023 to Sep 2024